Sign inGet started

NASDAQ:ALT

Altimmune, Inc.CIK 1326190 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
7

AI insights for NASDAQ:ALT PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for NASDAQ:ALT
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Roberts M ScotChief Scientific Officer4$0$02017-05-04
Schafer KlausDirector5$0$02017-05-04
Tasker SybilSee Remarks1$0$02017-05-04
Redmont Venture Partners, Inc.10% Owner3$0$02017-05-04
Enright WilliamSee Remarks6$0$02017-05-04
Drutz DavidDirector8$0$02017-05-04
CZEREPAK ELIZABETHSee Remarks2$0$02017-05-04

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Drutz DavidDirector A Award deriv2017-05-042017-05-084,178— $04,178SEC↗
Drutz DavidDirector A Award deriv2017-05-042017-05-082,090— $02,090SEC↗
Drutz DavidDirector A Award deriv2017-05-042017-05-084,178— $04,178SEC↗
Drutz DavidDirector A Award deriv2017-05-042017-05-084,177— $04,177SEC↗
Drutz DavidDirector A Award deriv2017-05-042017-05-084,755— $04,755SEC↗
Drutz DavidDirector A Award deriv2017-05-042017-05-081,791— $01,791SEC↗
Drutz DavidDirector A Award deriv2017-05-042017-05-081,791— $01,791SEC↗
CZEREPAK ELIZABETHSee Remarks A Award deriv2017-05-042017-05-08178,595— $0178,595SEC↗
CZEREPAK ELIZABETHSee Remarks A Award deriv2017-05-042017-05-0818,727— $018,727SEC↗
Enright WilliamSee Remarks A Award deriv2017-05-042017-05-08125,887— $0125,887SEC↗
Enright WilliamSee Remarks A Award deriv2017-05-042017-05-0891,733— $091,733SEC↗
Enright WilliamSee Remarks A Award deriv2017-05-042017-05-08183,347— $0183,347SEC↗
Enright WilliamSee Remarks A Award deriv2017-05-042017-05-0871,644— $071,644SEC↗
Enright WilliamSee Remarks A Award deriv2017-05-042017-05-0899,927— $099,927SEC↗
Roberts M ScotChief Scientific Officer A Award deriv2017-05-042017-05-0811,235— $011,235SEC↗
Roberts M ScotChief Scientific Officer A Award deriv2017-05-042017-05-088,956— $08,956SEC↗
Roberts M ScotChief Scientific Officer A Award deriv2017-05-042017-05-0855,120— $055,120SEC↗
Roberts M ScotChief Scientific Officer A Award deriv2017-05-042017-05-088,956— $08,956SEC↗
Schafer KlausDirector A Award deriv2017-05-042017-05-084,775— $04,775SEC↗
Schafer KlausDirector A Award deriv2017-05-042017-05-081,791— $01,791SEC↗
Schafer KlausDirector A Award deriv2017-05-042017-05-081,791— $01,791SEC↗
Schafer KlausDirector A Award deriv2017-05-042017-05-081,791— $01,791SEC↗
Tasker SybilSee Remarks A Award deriv2017-05-042017-05-0848,691— $048,691SEC↗
Drutz DavidDirector A Award2017-05-042017-05-0820,777— $020,777SEC↗
Enright WilliamSee Remarks A Award2017-05-042017-05-0817,787— $017,787SEC↗
Redmont Venture Partners, Inc.10% Owner A Award2017-05-042017-05-0836,785— $036,785SEC↗
Redmont Venture Partners, Inc.10% Owner A Award2017-05-042017-05-081,278,471— $01,278,471SEC↗
Redmont Venture Partners, Inc.10% Owner A Award2017-05-042017-05-084,455— $04,455SEC↗
Schafer KlausDirector A Award2017-05-042017-05-085,998— $05,998SEC↗